[New] The International Maize and Wheat Improvement Center based in Mexico has been testing genetically engineered wheat, and new facilities partially funded by the Bill and Melinda Gates Foundation will enable further research in GM maize and wheat.
GMO Answers
[New] In recent research, Cornell biologists identified a surprising mechanism that weakens bacteria from within - an insight that could guide the next generation of antibiotics as drug resistance rises worldwide.
Cornell Chronicle
[New] Modeling results indicate that widespread adoption of gene-edited, low-lignin feedstocks could reduce pulping-related GHG emissions by 20-50%, lower chemical and energy consumption, and deliver cost savings exceeding $6 billion annually.
International Fiber Journal
[New] Sanofi has 12 new drug candidates, including Amlitelimab and Frexalimab, as next-generation drugs and aims to achieve annual sales of more than €1 billion by 2030.
ABITA LLC&MARKETING JAPAN
[New] The development of next-generation drugs promoted by Sanofi is attracting a great deal of attention in envisioning the future of medicine for 2030.
ABITA LLC&MARKETING JAPAN
[New] The launch of Sanofi's next-generation drugs will revolutionize the medical landscape.
ABITA LLC&MARKETING JAPAN
[New] Companies like 23andMe are already offering genetic testing kits that provide insights into an individual's health risks and traits.
HR Fraternity
[New] In addition to providing genetic counseling, Amazon offers genetic testing services to its employees, allowing them to uncover hidden health risks and take proactive measures to prevent diseases.
HR Fraternity
[New] If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 5.24% move between the lowest and the highest trading price during the day.
StockInvest.us
[New] Opus Genetics reports that a phase 1/2 trial of its investigational gene therapy OPGx-BEST 1 will begin by the end of 2025.
PentaVision
[New] Producers may be surprised to know that there are a lot more opportunities to influence the performance of a bovine through the genetics of the rumen microbes than the actual bovine genome.
CNS Media
[New] Muscle-preserving drugs could generate $30 billion by 2035.
Business Insider
[New] A new long-term study from nutrition and genetics researchers at Harvard Medical School suggests that sticking to a healthy diet, specifically a Mediterranean one, can cut your risk of Alzheimer's, particularly if you have the APOE4 / 4 gene.
Business Insider
[New] The Honda 0 Saloon, the flagship model of the Honda 0 Series, is based on the newly developed dedicated EV architecture and will feature a number of next-generation technologies that embody the Thin, Light, and Wise development approach of the Honda 0 Series.
SME Street
[New] By 2030, companies such as GM and Stellantis expect to generate more than $20bn annually from subscription services.
Automotive Manufacturing Solutions
[New] The significant capital investments necessary to maintain progress in LLMs and GPU capacity to meet demands for compute is forcing the U.S. down a path that assumes Generative AI is an architecture that will not be improved upon soon.
AI Supremacy
Scientists working for an Oregon research institution had, by applying a form of the Dolly technique, achieved a breakthrough in cloning human embryos that could be used as healthy embryonic stem cell sources.
EBSCO Information Services, Inc. | www.ebsco.com
There are studies showing that higher dietary antioxidant intake, including with lutein and zeaxanthin, can significantly reduce early AMD associated with genetic risk variants.
PubMed Central (PMC)
The successful commercialization of new targeted biological medicines by companies will strengthen the UK manufacturing community with direct impacts on people employed and UK wealth generated.
UKRI, Polaris House, North Star Avenue, Swindon, SN2 1E
India's target is to generate 100 GW of nuclear energy capacity by 2047.
ThePrint
Last updated: 07 September 2025
Hi,
Would you like a quick online demo of our service from an experienced member of our team?